Koichi Sugihara Selected Research

Nontuberculous Mycobacterium Infections

12/2020

The development of rapidly progressive glomerulonephritis associated with both antineutrophil cytoplasmic antibody-associated vasculitis and anti-glomerular basement membrane nephritis in the course of nontuberculous mycobacterium infection: a case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koichi Sugihara Research Topics

Disease

3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2022 - 01/2022
2	Premature Birth (Birth, Premature) 04/2023 - 01/2022
2	COVID-19 10/2022 - 07/2022
2	Rheumatic Diseases (Rheumatism) 10/2022 - 07/2022
2	Nephritis 09/2022 - 12/2020
1	Pain (Aches) 05/2023
1	Chronic recurrent multifocal osteomyelitis 05/2023
1	Familial Mediterranean Fever (Periodic Disease) 05/2023
1	Birth Weight (Birth Weights) 04/2023
1	Atherosclerosis 11/2022
1	Leukopenia 09/2022
1	malar rash 09/2022
1	Alopecia (Baldness) 09/2022
1	Angioedema 09/2022
1	Arthralgia (Joint Pain) 09/2022
1	Thrombocytopenia (Thrombopenia) 09/2022
1	Rheumatoid Arthritis 01/2022
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Spontaneous Remission 01/2022
1	Oral Ulcer (Mouth Ulcer) 01/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2021
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 09/2021
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2021
1	Otitis Media 01/2021
1	Endarteritis 12/2020
1	Nontuberculous Mycobacterium Infections 12/2020
1	Infections 12/2020
1	Communicable Diseases (Infectious Diseases) 12/2020
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 12/2020
1	Vasculitis (Vasculitides) 12/2020
1	Inflammation (Inflammations) 12/2020
1	Glomerulonephritis 12/2020
1	Fever (Fevers) 12/2020

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 11/2022 - 01/2022
3	Immunosuppressive Agents (Immunosuppressants)IBA 10/2022 - 01/2021
2	GlucocorticoidsIBA 04/2023 - 01/2022
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2022 - 01/2022
2	COVID-19 VaccinesIBA 10/2022 - 07/2022
2	Messenger RNA (mRNA)IBA 10/2022 - 07/2022
2	BNT162 VaccineIBA 10/2022 - 07/2022
2	Proteins (Proteins, Gene)FDA Link 10/2022 - 07/2022
2	SARS-CoV-2 spike proteinIBA 10/2022 - 07/2022
2	Immunoglobulin G (IgG)IBA 07/2022 - 12/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 09/2021
1	Colchicine FDA LinkGeneric 05/2023
1	LipidsIBA 11/2022
1	AdipokinesIBA 11/2022
1	VaccinesIBA 10/2022
1	Interleukin-17 (Interleukin 17)IBA 10/2022
1	Antinuclear AntibodiesIBA 09/2022
1	AntigensIBA 09/2022
1	RNA (Ribonucleic Acid)IBA 07/2022
1	mRNA VaccinesIBA 07/2022
1	Immunoglobulin M (IgM)IBA 07/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	apremilastIBA 01/2022
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	tocilizumab (atlizumab)FDA Link 09/2021
1	mepolizumabIBA 01/2021
1	InterleukinsIBA 01/2021
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2020
1	AntibodiesIBA 12/2020
1	antiglomerular basement membrane antibodyIBA 12/2020

Therapy/Procedure

3	Therapeutics 11/2022 - 01/2021
1	Drug Therapy (Chemotherapy) 01/2022